Other OTC Pharmaceuticals - United States

United States

Highlights

In 2024, the revenue in the Other OTC Pharmaceuticals market in the United States amounted to US$7.17bn.
This market is projected to experience an annual growth rate of 0.94% (CAGR 2024-2029).
It is worth noting that the United States leads in terms of revenue generation, with US$7.17bn in 2024.
When considering the population size, per person revenues in 2024 reached US$20.98.
The United States is experiencing a surge in demand for natural and herbal remedies in the Other OTC Pharmaceuticals market.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in United States is experiencing significant growth and development.

Customer preferences: Customers in the United States have shown a strong preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors. Firstly, the convenience of purchasing OTC medications without a prescription appeals to consumers who want to avoid the hassle of visiting a doctor. Additionally, the lower cost of OTC medications compared to prescription drugs is a major factor driving customer preference. Many individuals are looking for affordable healthcare options, and OTC pharmaceuticals provide a cost-effective solution. Furthermore, the increasing focus on self-care and wellness has led to a rise in demand for OTC products, as consumers take a proactive approach to managing their health.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in United States is the growing demand for natural and herbal remedies. Consumers are increasingly seeking products that are perceived as more natural and have fewer side effects. This trend is driven by a desire for holistic and alternative healthcare options. As a result, companies in the OTC pharmaceutical industry are expanding their product offerings to include more natural and herbal remedies. Another trend in the market is the increasing availability and use of online platforms for purchasing OTC pharmaceutical products. E-commerce has become a popular channel for consumers to buy OTC medications, offering convenience and a wide range of product options. This trend has been further accelerated by the COVID-19 pandemic, as online shopping has become the preferred method for many consumers.

Local special circumstances: The United States has a well-established regulatory framework for OTC pharmaceuticals. The Food and Drug Administration (FDA) plays a crucial role in ensuring the safety and efficacy of these products. The FDA regulates the ingredients, labeling, and marketing of OTC medications, providing consumers with confidence in the products they purchase. This robust regulatory environment contributes to the growth of the Other OTC Pharmaceuticals market in United States by ensuring that products meet the necessary quality standards. Additionally, the United States has a highly competitive market for OTC pharmaceuticals. There are numerous players in the industry, ranging from large multinational corporations to smaller local companies. This competition drives innovation and product development, as companies strive to differentiate themselves and capture market share.

Underlying macroeconomic factors: Several macroeconomic factors are driving the growth of the Other OTC Pharmaceuticals market in United States. Firstly, the aging population is a significant driver of demand for OTC medications. As the population ages, there is an increased prevalence of chronic conditions and a greater need for self-care and symptom management. This demographic trend is expected to continue in the coming years, further fueling the growth of the OTC pharmaceutical market. Additionally, the increasing healthcare costs in the United States are leading consumers to seek more affordable alternatives. OTC medications provide a cost-effective option for individuals who are looking to manage their health without incurring high medical expenses. Furthermore, the growing emphasis on preventive healthcare and wellness is driving the demand for OTC products. Consumers are taking proactive measures to maintain their health and prevent the onset of diseases, creating a favorable market environment for OTC pharmaceuticals.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.